Finally, germline polymorphisms of the genes encoding relevant immune checkpoints (CTLA4, PDCD1, and PDL1) have been implicated in cancer risk [61], with signals from small retrospective studies starting to emerge that particular alleles may also associate with ICI benefit [62, 63, 64, 65]. Here, CD274 is linked to cancer.